Dr. Lin serves as Chief Medical Officer for iHealth Innovation Tech and Chair of the Scientific Advisory Board. His unique background in medicine, science, research and business provides important strategic guidance for the company. Dr. Lin graduated from prestigious academic medical institutions and has extensive experience in the healthcare and medical industries.
After graduating from Northwestern University Feinberg School of Medicine with MD and PhD degrees, he completed his residency in Pathology and fellowship in Molecular Genetic Pathology at UCLA David Geffen School of Medicine. In addition to his medical and scientific degrees, he also completed his MBA from the USC Marshall School of Business. A physician-scientist, board-certified pathologist, and healthcare strategist, Erick brings experience across FDA regulation, diagnostics, healthcare AI, precision medicine, market access, and commercialization. He previously served as a Medical Officer in the FDA's Digital Health Center of Excellence and has held leadership and advisory roles at the Blue Cross Blue Shield Association, Ambry Genetics, and PathAI.
Erick is passionate about connecting breakthrough science with everyday health. His work focuses on translating promising innovations into practical, evidence-based solutions that are accessible and scalable. Using his extensive education, training and work experience, Dr. Lin has been instrumental in ensuring iHealth Innovation Tech continues to stay at the forefront of the health and wellness industries, from nutrition to beauty care.
At iHealth, his focus includes evidence-based longevity, preventive health, biomarkers, and emerging technologies that can help people live longer, healthier lives. He brings a scientific and clinical perspective to evaluating new opportunities and communicating their potential clearly.
His mission: Making the science of longevity accessible to everyone.
